TFX on NYSE

Teleflex

Logo: Teleflex Incorporated, Public domain, via Wikimedia Commons5

American medical device company

Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has operations in 40 countries, and more than 15,000 employees.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 19, 2026.

Overview

1943Founded1

Compare with ICU Medical, INTEGRA LIFESCIENCES HOLDINGS CORP or MERIT MEDICAL SYSTEMS INC, or pick any stock.

  • TickerTFX on NYSE1
  • Industrymedical device design1
  • HeadquartersWayne1
  • Websitewww.teleflex.com
  • Legal formDelaware corporation1
  • Incorporated inDE6
  • Business address550 E Swedesford Rd, Suite 400, Wayne, Pa 190876
  • Filer categoryLarge accelerated filer6
  • LEIUUL85LWXB4NGSWWXIQ254
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressC/O THE PRENTICE-HALL CORPORATION SYSTEM, INC., 19808 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 3864214

Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with Irish corporate tax avoidance tools. Teleflex's chief executive officer (CEO) and president is Jason Weidman.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

56.2%Gross margin8
5.9%Operating margin8
-45.4%Net margin8
17.2%Revenue growth, 20258
-29.0%Return on equity8
0.81×Debt to equity8

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Vascular Access brought in 46% of the revenue Teleflex broke down this way in fiscal 2025.

  1. Vascular Access$917.7M846%up 2% from 2024
  2. Interventional$647.8M833%up 63% from 2024
  3. Surgical$418.2M821%up 3% from 2024
  4. Other$9.0M80%up 246% from 2024
Products and services by year
Products and services202320242025
Vascular Access$841.1M$903.5M$917.7M
Interventional$407.3M$397.3M$647.8M
Surgical$388.3M$404.9M$418.2M
Other$75.8M-$6.2M$9.0M

Business segments

Americas brought in 64% of the revenue Teleflex broke down this way in fiscal 2025.

  1. Americas$1.3B864%up 11% from 2024
  2. EMEA$472.4M824%up 39% from 2024
  3. Asia$241.1M812%up 19% from 2024
Business segments by year
Business segments202320242025
Americas$1.2B$1.2B$1.3B
EMEA$317.0M$340.3M$472.4M
Asia$214.8M$202.3M$241.1M

Regions

United States brought in 59% of the revenue Teleflex broke down this way in fiscal 2025.

  1. United States$1.2B859%up 9% from 2024
  2. Europe$484.7M824%up 39% from 2024
  3. Asia And Asia Pacific$218.0M811%up 21% from 2024
  4. All Other$108.1M85%up 17% from 2024
Regions by year
Regions202320242025
United States$1.1B$1.1B$1.2B
Europe$330.1M$347.9M$484.7M
Asia And Asia Pacific$187.9M$179.6M$218.0M
All Other$87.5M$92.7M$108.1M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue44¢$872.0M
  • Research and development7¢$144.8M
  • Selling, general and admin36¢$720.2M
  • Other costs11¢$221.8M
  • Income tax2¢$34.0M

Out of $2.0B in revenue.8 The company lost money this year.

Financial statements

Revenue91011128$2.0B in 2025−23% since 2019
0$1.0B$2.0B$3.0B2019: $2.6B$2.6B20192020: $2.5B$2.5B2020−2%2021: $2.8B$2.8B2021+11%2022: $2.8B$2.8B2022−1%2023: $1.7B$1.7B2023−39%2024: $1.7B$1.7B2024−1%2025: $2.0B$2.0B2025+17%
Gross profit91011128$1.1B in 2025−20% since 2019
0$500.0M$1.0B$1.5B$2.0B2019: $1.4B$1.4B20192020: $1.3B$1.3B2020−6%2021: $1.5B$1.5B2021+17%2022: $1.5B$1.5B2022−1%2023: $1.0B$1.0B2023−32%2024: $1.0B$1.0B2024−0%2025: $1.1B$1.1B2025+8%
Operating income91011128$118.4M in 2025−72% since 2019
0$200.0M$400.0M$600.0M$800.0M2019: $427.3M$427.3M20192020: $423.1M$423.1M2020−1%2021: $628.1M$628.1M2021+48%2022: $499.7M$499.7M2022−20%2023: $258.7M$258.7M2023−48%2024: $103.7M$103.7M2024−60%2025: $118.4M$118.4M2025+14%
Net income91011128-$905.6M in 2025
-$1.0B-$500.0M0$500.0M2019: $461.5M$461.5M20192020: $335.3M$335.3M2020−27%2021: $485.4M$485.4M2021+45%2022: $363.1M$363.1M2022−25%2023: $356.3M$356.3M2023−2%2024: $69.7M$69.7M2024−80%2025: -$905.6M-$905.6M2025

Every line of the income statement as filed: the last 3 fiscal years (annual) or 8 quarters (quarterly), latest first.8

Period ending2025-12-312024-12-312023-12-31
Net revenues$2.0B$1.7B$1.7B
Cost of goods sold$872.0M$662.2M$672.3M
Gross profit$1.1B$1.0B$1.0B
Selling, general and administrative expenses$720.2M$674.5M$622.7M
Research and development expenses$144.8M$109.0M$113.6M
Pension settlement charge$0$132.7M$45.2M
Restructuring charges, separation costs and impairment charges$137.4M$17.5M$4.2M
Gain on sale of assets and business$0$0-$4.4M
Income from continuing operations before interest and taxes$118.4M$103.7M$258.7M
Interest expense$100.2M$83.5M$85.0M
Interest income-$6.4M-$6.2M-$11.7M
Income from continuing operations before taxes$24.6M$26.3M$185.4M
(Benefit) taxes on income from continuing operations-$34.0M-$30.9M$41.9M
Income from continuing operations$58.5M$57.2M$143.5M
Operating (loss) income from discontinued operations-$1.1B$48.6M$247.0M
(Benefit) taxes on operating loss from discontinued operations-$133.0M$36.1M$34.2M
(Loss) income from discontinued operations-$964.2M$12.5M$212.8M
Net (loss) income-$905.6M$69.7M$356.3M
Income (loss) from continuing operations (in dollars per share)$1$1$3
Loss from discontinued operations (in dollars per share)-$22$0$5
Net income (in dollars per share)-$20.30$1.49$7.58
Income from continuing operations (in dollars per share)$1$1$3
(Loss) income from discontinued operations (in dollars per share)-$22$0$4
Net income (loss), diluted (in dollar per share)-$20.25$1.48$7.53
Basic (in shares)44.6M shares46.8M shares47.0M shares
Diluted (in shares)44.7M shares47.1M shares47.3M shares

Compare Teleflex with another company

The story

Teleflex was founded in 1943. Over time the business expanded into a conglomerate operating in multiple markets, often through acquisitions, such as:

Franklin Medical Ltd (1985)

Warne Surgical Products Ltd (1985)

Willy Rüsch AG (1989)

Pilling (1991)

Access Surgical (1993)

Nextex (1993)

Unimed (1994)

Read the full text

General Medical OEM Division (1994)

Europe Medical (1994)

Fehling (1994)

Simal (1994)

Endoscopy Specialists, Inc. (1995)

Asid Bonz (1996)

Comcorp Technologies, Inc. (1997)

Z-Medica (2020)

In general these acquisitions moved the business further into the design, build and supply of medical devices, a move that had begun in 1981 with the construction of the Applied Polymer plant in New Hampshire. Several acquisitions were not in line with this strategy. Comcorp, for example, was a supplier of pedals and other components for passenger cars and light-duty trucks and Nextex a fiber-optic communications business.

Refocus on the medical device sector began in March 2009 when Teleflex sold its marine and industrial instrumentation (gauge) business to Veethree, and planned to exit its Lakewood Ranch, Florida facility. Veethree subsequently continued production of former Teleflex products at its Manatee County, Florida facility and hired approximately 50 workers from Teleflex.

In March 2011, Teleflex sold its marine division, Teleflex Marine, to H.I.G. Capital.

In August 2012, Teleflex substantively finalized an agreement to acquire all assets of the medical device maker LMA International, thereby expanding the company's anesthesia device franchise.

In December 2013, Teleflex completed the acquisition of Vidacare Corporation, integrating Vidacare's intraosseous EZ-IO and OnControl medical devices into Teleflex's Arrow product line.

On September 5, 2017, Teleflex announced that it had entered into a definitive agreement to acquire NeoTract in a transaction valued at up to $1.1B USD. Under the terms of the agreement, Teleflex will acquire NeoTract for an up-front cash payment of $725M USD and up to an additional $375M USD contingent on the achievement of certain sales-related commercial milestones through December 31, 2020. The transaction was unanimously approved by the Boards of Directors for both Teleflex and NeoTract.

On January 18, 2019, S&P Dow Jones Indices added Teleflex to its S&P 500 stock market index, replacing PG&E in the index after the utility company declared bankruptcy.

On March 24, 2025, S&P Dow Jones Indices removed Teleflex from its S&P 500 stock market index.

From Wikipedia’s article on Teleflex, shared under CC BY-SA 4.0.7

Leadership

Who has led Teleflex, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (57)

Subsidiaries and ownership

Subsidiaries

From Wikidata.1

Timeline

  1. Jun 9, 2026New chief executive Jason R. Weidman becomes CEO17
  2. Jan 15, 2026New chief executive Stuart A. Randle becomes CEO16
  3. Feb 27, 2018New chief executive Liam Kelly becomes CEO18
  4. Mar 1, 2011New chief executive Benson Smith becomes CEO19
  5. Oct 27, 2003New chief executive Jeffrey P. Black becomes CEO20
  6. Jan 2, 1990Went public Listed on NYSE1
  7. 1943Founded Founded1

Filings

294 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 52 major events, 154 insider forms, 39 large holders, 29 other. The latest 20:

  1. Sep 10, 20264 EDGAR
  2. Sep 10, 20263 EDGAR
  3. Sep 9, 20268-K EDGAR
  4. Sep 8, 2026SCHEDULE 13G/A EDGAR
  5. Aug 14, 2026SCHEDULE 13G/A EDGAR
  6. Aug 7, 20268-K EDGAR
  7. Aug 6, 202610-Q EDGAR
  8. Aug 6, 20268-K EDGAR
  9. Aug 5, 20268-K/A EDGAR
  10. Aug 3, 20268-K EDGAR
  11. Jun 26, 202611-K EDGAR
  12. Jun 15, 20268-K EDGAR
  13. Jun 9, 20264 EDGAR
  14. Jun 9, 20264 EDGAR
  15. Jun 9, 20263 EDGAR
  16. Jun 9, 20268-K EDGAR
  17. Jun 2, 20268-K EDGAR
  18. Jun 1, 20268-K EDGAR
  19. May 28, 2026SD EDGAR
  20. May 27, 20268-K EDGAR

The 294 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

15 open-market trades by officers, directors and large owners since October 2021: 6 buys and 9 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 6, 2025HAGGERTY GRETCHEN RDirectorBuy500$114.75$57.4KForm 4
Aug 5, 2025RANDLE STUART ADirectorBuy1,000$115.86$115.9KForm 4
Aug 5, 2025Krakauer Andrew ADirectorBuy1,000$115.25$115.2KForm 4
Aug 5, 2025Kelly LiamChairman, President & CEOBuy1,500$115.07$172.6KForm 4
Aug 5, 2025Ryu JaewonDirectorBuy1,500$115.00$172.5KForm 4
Aug 16, 2024RANDLE STUART ADirectorSale2,674$238.93$638.9KForm 4
Mar 5, 2024Hicks Cameron PCorp. VP & Chief HR OfficerSale7,401$225.00$1.7MForm 4
Dec 27, 2023Kelly LiamChairman, President & CEOSale26,256$250.23$6.6MForm 4
Nov 29, 2023POWELL THOMAS EExecutive Vice President & CFOSale13,952$222.88$3.1MForm 4
May 10, 2023RANDLE STUART ADirectorSale3,021$245.71$742.3KForm 4
Dec 30, 2022Kelly LiamChairman, President & CEOSale16,343$250.03$4.1MForm 4
Jun 7, 2022RANDLE STUART ADirectorSale3,014$283.31$853.9KForm 4
Dec 27, 2021Kelly LiamChairman, President & CEOSale8,987$330.00$3.0MForm 4
Nov 30, 2021Krakauer Andrew ADirectorBuy1,000$307.23$307.2KForm 4
Nov 10, 2021Hicks Cameron PCorp. VP & Chief HR OfficerSale3,600$350.00$1.3MForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.5,431,818$688.5M0.0%+39,827
Jupiter Topco LLC4,342,512$550.5M0.2%New
Vanguard Portfolio Management LLC2,416,998$306.4M0.0%−21,185
Vanguard Capital Management LLC1,995,717$253.0M0.0%+11,893
Sessa Capital IM, L.P.1,526,228$193.5M3.3%No change
State Street Corp1,484,039$188.1M0.0%−18,818
Millennium Management LLC1,442,103$182.8M0.1%+760,045
Fuller & Thaler Asset Management, Inc.1,320,946$167.4M0.5%−43,004
Dimensional Fund Advisors LP1,152,695$146.1M0.0%+155,551
Citadel Advisors LLC1,140,950$144.6M0.1%−30,146
Geode Capital Management, LLC1,039,977$131.9M0.0%+41,557
Cooke & Bieler LP1,011,666$128.2M1.5%−131,008
Goldman Sachs Group Inc905,779$114.8M0.0%+707,189
Holocene Advisors, LP886,281$112.3M0.3%+470,946
Irenic Capital Management LP870,000$110.3M7.9%No change
Abrams Bison Investments, LLC793,000$100.5M4.9%−207,000
Norges Bank684,425$86.8M0.0%New
Pzena Investment Management LLC603,206$76.5M0.2%−95,919
Morgan Stanley591,301$75.0M0.0%+55,122
Invesco Ltd.573,914$72.7M0.0%+438,868
River Road Asset Management, LLC548,173$69.5M0.8%−373,943
Charles Schwab Investment Management Inc534,218$67.7M0.0%+14,433
Arrowstreet Capital, Limited Partnership490,277$62.1M0.0%−148,484
Bank Of America Corp /de/482,457$61.2M0.0%+36,499
Capital International Investors468,615$59.4M0.0%+12,790

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

13 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Jul 22, 2025Lisa C. McClainRepublican, HouseSale$1,001 - $15,000+11.4%Report
Jul 16, 2025Lisa C. McClainRepublican, HouseBuy$1,001 - $15,000−10.5%Report
Feb 25, 2025Robert P. Bresnahan, Jr.Republican, HouseSale$1,001 - $15,000+57.7%Report
Jul 12, 2023Daniel S. GoldmanDemocratic, HouseSale$15,001 - $50,000+121.1%Report
Apr 10, 2023Daniel S. GoldmanDemocratic, HouseBuy$15,001 - $50,000−139.4%Report
Nov 30, 2022Susie LeeDemocratic, HouseSale$1,001 - $15,000+134.5%Report
Jun 28, 2021Susie LeeDemocratic, HouseBuy$1,001 - $15,000−149.0%Report
Dec 16, 2020Susie LeeDemocratic, HouseBuy$1,001 - $15,000−176.2%Report
Dec 8, 2020Susie LeeDemocratic, HouseBuy$1,001 - $15,000−175.0%Report
Dec 3, 2020Susie LeeDemocratic, HouseBuy$1,001 - $15,000−176.6%Report
May 19, 2020Susie LeeDemocratic, HousePartial sale$1,001 - $15,000+227.2%Report
Apr 28, 2020Susie LeeDemocratic, HousePartial sale$1,001 - $15,000+232.4%Report
Dec 27, 2019Susie LeeDemocratic, HousePartial sale$1,001 - $15,000+204.6%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97